Cat HCM Medication: Managing Heart Failure in Practice

Medical management of feline hypertrophic cardiomyopathy reduces symptoms and improves quality of life, though it cannot reverse the underlying disease.

Key Facts

Congestive heart failure (CHF) secondary to HCM is managed primarily with furosemide to reduce fluid accumulation.
Atenolol may be used to reduce heart rate and diastolic dysfunction in selected cases.
Clopidogrel (Plavix) is prescribed to reduce thromboembolic risk in cats with enlarged left atria.
Rivaroxaban is an alternative anticoagulant with daily oral dosing that is better tolerated by some cats.
Regular chest radiographs and echocardiography guide medication adjustments.
The median survival time after first CHF episode in cats is approximately 6-12 months.

Welfare Considerations

Medical management of HCM-related CHF allows cats to live comfortably for months after a first congestive episode. The priority is reducing respiratory distress and preventing recurrence. Owner education about monitoring respiratory rate at home (target below 30 breaths per minute at rest) allows early detection of decompensation. Quality-of-life deterioration typically precedes death; proactive euthanasia planning is an essential component of compassionate cardiac care.

What You Can Do

Monitor your cardiac cat's resting respiratory rate daily; contact your vet if it exceeds 30 breaths per minute.
Give all cardiac medications at consistent times each day; never skip doses without veterinary guidance.
Discuss anticoagulant therapy with your veterinary cardiologist to reduce thromboembolic risk.
Plan euthanasia criteria in advance with your vet to ensure a peaceful death before severe respiratory distress.